Intensity Therapeutics is a clinical stage, biotechnology company whose mission is to greatly extend the lives of cancer patients. Our lead product, INT230-6, is currently in human clinical testing to treat refractory solid tumor cancers.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.